FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, particularly to attenuated Bordetella pertussis bacteria, which contains mutations in the regulatory and coding regions of the operon ptx and the coding region of the dnt gene, for use as a pertussis vaccine. Invention also discloses a strain of attenuated Bordetella pertussis bacteria, a lyophilized preparation thereof, a lyophilisation method thereof and a Bordetella pertussis bacteria vaccine.
EFFECT: invention solves the task of lyophilic drying of attenuated Bordetella pertussis bacteria, which enables to obtain live pertussis vaccines.
6 cl, 4 ex, 1 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
ATTENUATED BACTERIA BORDETELLA PERTUSSIS, WHOOPING COUGH AGENT VACCINE | 2010 |
|
RU2455024C1 |
ASSESSMENT METHOD FOR PROTECTIVE POTENCY OF PERTUSSIS VACCINES | 2015 |
|
RU2623314C2 |
METHODS FOR ASSESSING THE PROTECTIVE ACTIVITY AND IMMUNOGENICITY OF PERTUSSIS VACCINES IN HUMANS, THE USE OF LIVE PERTUSSIS RECOMBINANT VACCINE GamFA | 2021 |
|
RU2799018C2 |
METHOD FOR MOLECULAR-GENETIC GROUPING OF STRAINS Bordetella pertussis | 2012 |
|
RU2495132C1 |
IMPROVED Bordetella pertussis VACCINES BASED ON MUTANT GLYCOSYLTRANSFERASES LPS | 2008 |
|
RU2542667C2 |
METHOD OF PREPARING AN ATTENUATED STRAIN OF BACTERIUM SALMONELLA AND A VACCINE | 1992 |
|
RU2126447C1 |
METHOD FOR OBTAINING ANATOXIN Bordetella pertussis | 2013 |
|
RU2540144C1 |
NEWLY RECOVERED BORDETELLA PERTUSSIS BACTERIA STRAIN - PERTUSSIS TOXIN PRODUCER | 2009 |
|
RU2407788C1 |
FRESHLY ISOLATED STRAIN OF BORDETELLA PERTUSSIS BACTERIA - PRODUCER OF A COMPLEX OF PROTECTIVE ANTIGENS FOR PRODUCTION OF CELL-FREE PERTUSSIS VACCINE | 2018 |
|
RU2689903C1 |
METHOD FOR GENOTYPING BORDETELLA PERTUSSIS FROM CLINICAL SAMPLES BASED ON EMBEDDED PCR | 2023 |
|
RU2822353C1 |
Authors
Dates
2019-12-19—Published
2017-08-07—Filed